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We have developed an efficient conversion of amino iron oxides
to carbohydrate and protein derived nanoparticles with highly
conserved bioactivity through a combination of diazo transfer
and azide–alkyne click technology.
Magnetic nanoparticles (MNP) based on iron oxides have
attracted much attention for their eclectic applications in
biotechnology and medicine. These applications include use as
magnetic resonance imaging contrast agents,1 heating mediators
for cancer thermotherapy,2 magnetic force-based gene delivery,3
and selective separation and detection of biomolecules.4 The
appeal of MNP with diameters below 30–40 nm is due to their
exceptional magnetic properties and biocompatibility. In recent
years, the growing need of high-quality hybrid MNP for
biomedical purposes has stimulated many efforts towards the
development of general methods to achieve bioactive surface
engineered MNP. Current strategies mostly involve noncovalent
approaches such as biotin–streptavidin technology5 or substrate
passive adsorption.6 Alternatively, the formation of more stable
covalent connections between hydroxyl groups on the outer
particle surface and a suitable anchoring agent located in a specific
position of the target molecule has received broad attention.7,8 The
latter approach is definitely more specific, thus improving
the quality of the hybrid nanoparticles, but it suffers from the
necessity to effect a great deal of hard-working chemical modifica-
tions, that could be impracticable with complex biomolecules,
such as proteins.
A convenient route is represented by the Cu(I)-catalyzed azide–
alkyne cycloaddition (CuAAC), the ‘‘click’’ reaction.9 This
reaction has several advantages: 1) it may be performed in water,
buffered media or mixtures of aqueous/organic solvents; 2) usually
it is high yielding and it does not require temperature and pressure
control; 3) the two active functionalities (azide and alkyne groups)
are easily accessible and they are located orthogonally on the
respective coupling entities, thus avoiding homodimer formation,
such as in the case of disulfide bridges;10 4) the reaction is
irreversible and the resulting linkage is very stable owing to the
formation of a triazole ring. Although click reaction is rapidly
spreading in all areas of surface chemistry as a valuable method for
the efficient immobilization of organic molecules, the application
to MNP is still in its infancy.11,12 This concept has the potential
to open the way to a reliable labeling of bioactive molecules.
However, the practical limitation of the current strategies is that
they require multiple reactions with time consuming purification
and characterization steps. Hence, a simple and general protocol
for the efficient bioconjugation of MNP is still desired. In the
present paper, we propose a straightforward, one-step route to site-
specific immobilization of biologically relevant molecules onto
MNP. By exploiting a convenient in situ tandem combination of
diazo transfer and CuAAC reactions, we demonstrate that bio-
molecules such as carbohydrates and proteins can be easily
immobilized onto the surface of iron oxide nanoparticles retaining
their biological activity.
We used commercial c-Fe2O3 nanoparticles (Alpha Aesar) with
a size dispersion of 10 ¡ 4 nm and approximately spherical in
shape, as confirmed by TEM. Frequently, an initial step to
modified iron oxide nanoparticles involves their sonochemical
alteration with c-aminopropyl triethoxysilane in toluene or
water, leading to aminated nanoparticles MNP1. NH2-MNP
may also be easily accessed from dextran coated Fe3O4.
13 Our first
objective was to turn NH2-MNP into N3-MNP, necessary for
CuAAC reaction.
A high-yielding method alternative to traditional SN2 appro-
aches consists in the generation of azido functionalities from the
corresponding amines via the Cu(II)-catalyzed diazo transfer
reaction.14 We considered this strategy and applied it successfully
to MNP1, which were easily converted into azido MNP (MNP2).
MNP1 were suspended in a H2O/MeOH solution and treated with
freshly prepared trifluoromethanesulfonyl (triflic) azide dissolved
in the minimum amount of dichloromethane, in the presence of
triethylamine and catalytic CuSO4. Upon addition of the catalyst,
the surface amino groups rapidly turned into the corresponding
azides. The progress of the reaction can be monitored by ninhydrin
assay and the formation of the azide was observed by reflection
anisotropy spectroscopy (RAS) FTIR, which showed the appear-
ance of a strong absorbance at 2095 cm21 due to NLNLN
antisymmetric stretching.
In the course of this work, Beckmann et al. have reported a one-
pot procedure for diazo transfer and click reaction in solution.15 In
light of the above observations, we explored the possibility to
tether biomolecules to MNP1 via triazole formation without
recovering the intermediate azido derivative. The key point of our
method is the in situ generation of Cu(I) species required for
the Hu¨isgen cycloaddition, deriving it directly from Cu(II) salts
necessary for diazo transfer. Indeed, the addition of sodium
ascorbate after diazo transfer completion causes the reduction of
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Cu(II) to Cu(I), which, once formed, becomes immediately
available to promote the subsequent cross-reaction with the
complementary alkyne. The organic counterparts required for
CuAAC reaction were provided with an appropriate acetylenic
functionality. As a general strategy, we introduced a propargyl
group through a tetraethylene glycol chain (1), commonly
employed as a soluble bioinert spacer for bioconjugation.
A representative reaction protocol for a sequential one-pot
procedure is reported in Scheme 1 for the lactose derivative 3.
MNP1 were sonicated under above mentioned diazo transfer
conditions, affording MNP2, which accumulated within the
aqueous layer of a biphasic H2O–CH2Cl2 mixture. Sodium
ascorbate was then added to the mixture, followed by a solution
of previously synthesized precursor 3 (see ESI{ for the synthesis of
precursors 1–3). The mixture was sonicated for 2 h, resulting in a
water soluble dispersion of MNP3. MNP3 was recovered after
centrifugation, washed with water several times and dried under
vacuum. Elemental analysis and ICP-AES indicated that an
average of 835 ligands were clicked to each particle, corresponding
to 2.7 ligands per nm2. The same procedure was reproduced with 1
and 2, obtaining the corresponding MNP4 and MNP5, with
surface densities of 3.2 ligands per nm2 and 2.8 ligands per nm2,
respectively.
The derivatized particles MNP3-5 were characterized by FTIR,
high resolution magic angle spinning (HRMAS) NMR and TEM.
We observed our samples by attenuated total reflection (ATR) and
RAS FTIR. Infrared spectra of MNP3-5 showed a diagnostic
peak at 1550 cm21 in agreement with the literature value for a
1,2,3-triazole. Strong absorbance due to Si–O and Fe–O bonds
were evident at 1010–1032 cm21 and 453–533 cm21, respectively.
Characteristic bands owing to C–H were also identified at
2850 cm21 (stretching) and 1400–1500 cm21 (bending). 1H NMR
resolved spectra of ligands bound to a paramagnetic nanocrystal
are difficult to perform due to large broadening effects caused by
paramagnetic features.16 Since we have experienced HRMAS
NMR as a powerful spectroscopic technique for the characteriza-
tion of supported molecules, we explored the possibility to analyse
our MNP by HRMAS NMR. Actually, this method proved very
valuable for structure-resolved analysis of the organic layer of our
hybrid nanoparticles. Signals are sharp and well-resolved. The
presence of a peak at ca. 8 ppm in MNP3-5 NMR spectra due to
the triazole proton confirmed that 1,3 dipolar cycloaddition was
successful. The comparison with 1H NMR of 2 and 3 not only
confirmed the presence of sugar moieties on MNP3 and MNP5,
but also allowed us to attribute the respective carbohydrate
structures. Anomeric protons for lactose in MNP3 are located at
4.41 ppm (d, J = 10 Hz, b-galacto) and 4.48 ppm (d, J = 10 Hz,
b-gluco), while a-mannoside H-1 in MNP5 was shifted to 4.95 ppm
(s). HRMAS NMR spectra of MNP3 and MNP5 are included in
the ESI{.
As a proof of principle that our strategy is readily adaptable to
complex biomolecules, MNP were clicked to human serum
albumin (HSA). This plasma protein consisting of 585 amino
acids is involved in maintenance of osmotic pressure and transport
of endogenous and exogenous (drugs) substances. HSA includes
35 cysteine residues, 34 of which are involved in 17 disulfide bonds,
while the unpaired Cys34 is present as a free thiol.17 Therefore,
Cys34 is available for site-specific alkylation via Michael addition
by acrylamides. This labeling step is commonly used with any
protein provided with accessible cysteines without significant loss
of biological activity. We synthesized the alkyne-bearing acryl-
amide 4, in which tetraethylene glycol linker was introduced to
space out the protein from the MNP surface. HSA was reacted
with 4 at 37 uC in deionized water for 12 h, then dialyzed to
remove alkyne excess, and lyophilized. The amount of alkylated
protein was determined by titrating residual cysteine thiols with
Ellman’s reagent.18 We quantified that about 50% of the overall
HSA molecules were modified and we used this mixture in the
next experiments without further purification. The propargyl-
conjugated protein was successfully attached to MNP by following
our protocol (Scheme 2). In order to avoid possible protein
denaturation by contact with organic solvent, dichloromethane
was accurately removed by syringe before adding the protein. An
azido particle suspension in 0.1 M phosphate buffer, pH 7.0 (PB)
and Cu(II) from diazo transfer were incubated at 37 uC with
propargyl–HSA and sodium ascorbate and collected after 24 h by
means of a permanent magnet, obtaining the HSA–MNP
(MNP6). Several particle centrifugation–redispersion cycles were
effected to remove unreacted proteins until the supernatant was
protein-free (by ninhydrin test). Particles were purified by filtering
them through 0.45 mm pore septa, and characterized by ATR-
FTIR. The IR profile of MNP6 was similar to that of native
protein, confirming the presence of HSA molecules on the particle
surface. The filtered suspension was stable for months. As a
control, we attempted the same reaction with native HSA, but we
didn’t observe any reactivity, suggesting that MNP2 were sub-
stantially inert towards protein passive adsorption. After magnetic
recovery of MNP6, we determined the amount of loaded protein
Scheme 1 One-step synthesis of saccharide–MNP. Scheme 2 Immobilization of HSA onto MNP.
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by accurately measuring the residual intensity of Trp214 maximal
wavelength in the supernatant mother solution. This value was
then subtracted from the one relative to the initial HSA
concentration. This step was necessary for accurate quantification
of protein binding because scattering and absorption artifacts due
to iron oxide prevented the direct quantification of tryptophan
in the bound proteins. The amount of unreacted HSA was
fluorometrically determined after having first established a
standard calibration curve. On this basis, an average particle
coating of 7.5 HSA ligands pet MNP was estimated, correspond-
ing to about 84% coverage of the available surface area (details
and calculations are summarized in the ESI{).
With MNP6 in hand, we evaluated the bioactivity of HSA-
decorated MNP obtained by our method. Actually, it is well
documented that protein immobilization onto solid surfaces may
lead to partial or even complete denaturation.19 We tested our
nanoparticles observing the behavior of a MNP6 PB dispersion in
the presence of anti-HSA polyclonal antibody (Sigma). The
antiserum induces particle agglomeration by bridging couples of
HSA molecules situated on the respective nanoparticles (Scheme 3).
Such agglomeration was sensitively detected by accurate relaxo-
metric analysis of the particle dispersion (Table 1). An effect of the
formation of magnetic aggregates with more then 10–15 particles is
the decrease in the overall relaxivity of water protons, correspond-
ing to a detectable increment of spin–spin relaxation time T2.
In fact, owing to maghemite high density (4.9 g ml21), MNP
clusters above 400–500 nm may induce a loss of the colloidal status
of the particulate, thus sequestrating active contrast agent from
water solution, which significantly influences the relaxation rates.
Immunoprecipitation due to antigen–antibody interactions was
unambiguously detected at anti-HSA femtomoles. On the
contrary, additions of the same volumes of PB solution had a
minimal effect on the measured relaxivities due to dilution. As
evidenced in Table 1, relaxometric measurements after antiserum
additions revealed a time- and dose-dependent response of MNP6
to HSA-specific antibody, testifying to the retained biological
activity by anchored HSA molecules. The formation of MNP6
clusters was also confirmed by TEM analysis (Fig. 1).
In conclusion, we have reported a versatile, one-pot biofunction-
alization of MNP via diazo transfer followed by in situ CuAAC
reaction. In this context, we have also shown HRMAS as a
valuable technique enabling a structure-resolved 1H NMR surface
characterization of MNP. Moreover, we demonstrate that our
method is particularly suitable for protein immobilization,
resulting in a site-specific anchorage onto the nanoparticle surface,
which prevents loss of protein bioactivity. Exploiting the unique
magnetic properties of MNP, this approach may favour the
generation of novel diagnostic tools for active targeting.
We thank Dr P. S. Coghi for UV-visible spectra and
Dr F. Tedoldi for help in relaxometric investigations. The work
was supported by FIRB RBPR05NWWC, Cariplo foundation
and MIUR-COFIN 39903.
Notes and references
1 D. E. Sosnovik and R. Weissleder, Curr. Opin. Biotechnol., 2007, 18,
4–10.
2 S. Mornet, S. Vasseur, F. Grasset and E. Duguet, J. Mater. Chem.,
2004, 14, 2161–2175.
3 M. Chorny, B. Polyak, I. S. Alferiev, K. Walsh, G. Friedman and
R. J. Levy, FASEB J., 2007, 21, 2510–2519.
4 H. Gu, K. Xu, C. Xu and B. Xu, Chem. Commun., 2006, 941–949.
5 R. Narain, M. Gonzales, A. S. Hoffman, P. S. Stayton and
K. M. Krishnan, Langmuir, 2007, 23, 6299–6304.
6 K. Nishimura, M. Hasegawa, Y. Ogura, T. Nishi, K. Kataoka,
H. Handa and M. Abe, J. Appl. Phys., 2002, 91, 8555–8556.
7 A. J. Kell and B. Simard, Chem. Commun., 2007, 1227–1229.
8 M. Lewin, N. Carlesso, C.-H. Tung, X.-W. Tang, D. Cory,
D. T. Scadden and R. Weissleder, Nat. Biotechnol., 2000, 18, 410–414.
9 H. C. Kolb, M. G. Finn and K. B. Sharpless, Angew. Chem., Int. Ed.,
2001, 40, 2004–2021.
10 L. Tian, C. Shi and J. Zhu, Chem. Commun., 2007, 3850–3852.
11 M. A. White, J. A. Johnson, J. T. Koberstein and N. J. Turro, J. Am.
Chem. Soc., 2006, 128, 11356–11357.
12 P. C. Lin, S. H. Ueng, S. C. Yu, M. D. Jan, A. K. Adak, C. C. Yu and
C. C. Lin, Org. Lett., 2007, 9, 2131–2134.
13 E. Y. Sun, L. Josephson, K. A. Kelly and R. Weissleder, Bioconjugate
Chem., 2006, 17, 109–113.
14 P. T. Nyffeler, C. H. Liang, K. M. Koeller and C. H. Wong, J. Am.
Chem. Soc., 2002, 124, 10773–10778.
15 H. S. G. Beckmann and V. Wittmann, Org. Lett., 2007, 9, 1–4.
16 A. L. Willis, N. J. Turro and S. O’Brien, Chem. Mater., 2005, 17,
5970–5975.
17 D. C. Carter and J. X. Ho, Adv. Protein Chem., 1994, 45, 153–203.
18 G. L. Ellman, Arch. Biochem. Biophys., 1959, 82, 70–77.
19 D. Prosperi, C. Morasso, P. Tortora, D. Monti and T. Bellini,
ChemBioChem, 2007, 8, 1021–1028.
Scheme 3 Schematic antibody-induced MNP6 agglomeration.
Table 1 Activity of MNP6 towards anti-HSA by T2 measurement
a
[Anti-HSA]/
mg ml21 0.00 0.03 0.10 Ab/PBb
T2/ms (1 min) 2.14 ¡ 0.05 3.89 ¡ 0.05 6.06 ¡ 0.1 2788 ¡ 50
T2/ms (10 min) 2.16 ¡ 0.05 4.19 ¡ 0.05 12.46 ¡ 0.2 2796 ¡ 50
a T2 values were acquired at 37 uC in PB with a [MNP6] of
0.01 mg ml21. b This column reports T2 measured in absence of
MNP6.
Fig. 1 TEM images of different stages of MNP6 agglomeration in
response to addition of anti-HSA: A) 0.02 mg ml21 MNP6 in PB; B)
added 0.01 mg ml21 anti-HSA; C) added 0.10 mg ml21 anti-HSA.
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